Navigation Links
TapImmune, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2
Date:1/30/2017

JACKSONVILLE, Fla., Jan. 30, 2017 /PRNewswire/ -- TapImmune, Inc (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics for the treatment of cancer and metastatic disease, today announced that Glynn Wilson, Chief Executive Officer and Dr John Bonfiglio, Chief Operating Officer, will present live at VirtualInvestorConferences.com on February 2, 2017.

DATE: Thursday, February 2, 2017
TIME: 12:15pm Eastern Time
LINK: http://tinyurl.com/201prepr

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register and run the online system check to save time and receive event updates.

Learn more about the event at www.VirtualInvestorConferences.com.

TapImmune Corporate Highlights

  • Potential to be dominant player in T-cell cancer vaccines by eliciting both helper and killer T-cell responses
  • Evaluating lead candidate in four Phase 2 studies, some with FDA Fast Track and Orphan Disease Status
  • Highly vetted technology: Collaborations with Mayo Clinic, AstraZeneca, Memorial Sloan Kettering Cancer Center, U.S. Dept. of Defense
  • Compelling Phase 1 data show robust and enduring immune response against vaccine targets
  • Multiple upcoming clinical value inflection points

About TapImmune, Inc.

TapImmune Inc. is a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics for the treatment of cancer and metastatic disease. The Company's peptide or nucleic acid-based immunotherapeutics comprise one or multiple naturally processed epitopes (NPEs) designed to comprehensively stimulate patients' killer T-cells and helper T-cells, or to restore or further augment antigen presentation by using proprietary nucleic acid-based expression systems. The Company's technologies may be used as stand-alone medications or in combination with current treatment modalities, including immune checkpoint inhibitors.

Please visit the Company's website at www.tapimmune.com for more details.

About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tapimmune-inc-to-webcast-live-at-virtualinvestorconferencescom-february-2-300398493.html


'/>"/>
SOURCE TapImmune, Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. BioLight Israeli Life Sciences Investments Ltd. to Webcast, Live, at RetailInvestorConferences.com on September 12th
2. 22nd Century Group, Inc. CEO to Webcast, Live, at RetailInvestorConferences.com on December 5th
3. Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com September 11
4. NW Bio To Webcast, Live, at VirtualInvestorConferences.com On May 7
5. CohBar, Inc. to Webcast, Live, at VirtualInvestorConferences.com October 1
6. Cytori Therapeutics to Provide Corporate Update and Investor Presentation on December 4 through a Live, Interactive Webcast
7. Lightlake Therapeutics Inc. March 5th Presentation At VirtualInvestorConferences.com Now Available For On-Demand Viewing
8. Die Präsentation von Lightlake Therapeutics Inc. auf VirtualInvestorConferences.com vom 5. März steht jetzt auf Abruf zu Verfügung
9. ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7
10. Viveve to Webcast Live at VirtualInvestorConferences.com
11. DelMar Pharmaceuticals to Present an Interactive Live Webcast at VirtualInvestorConferences.com on October 1, 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):